✳ Modern medicine · Strength · Nutrition · Human coaching
Explore the clinical conversation.
Your starting goal can guide the questions. Explore therapies and supportive options that Dr. Schaffner may consider alongside the real-life foundations of care.
Tirzepatide at an individualized dose and BPC-157 may come up when clinically relevant. Neither is a default treatment. A membership category does not establish an indication, prescription or access to a product.
Explore the clinical conversation
Three paths. Individual decisions.
Choose a membership focus, then select an example for a simple description and questions to bring to Dr. Schaffner.
01 / Fat loss
Weight Loss
A muscle-first body-composition path. Clinical discussions begin with your history, nutrition and strength needs—not a standard peptide bundle.
Discussed across all paths
Additional Weight Loss conversations
01 / Fat loss · 01 / 03
Tirzepatide
Individual dosing considered across paths
- What it is
- Tirzepatide is the active ingredient in FDA-approved prescription medicines for specific conditions. Forme’s membership path alone is not an indication for treatment.
- Discuss with Dr. Schaffner
- Dr. Schaffner determines whether tirzepatide is appropriate, which product and dose to consider, contraindications, monitoring and how to support nourishment and muscle. No dose is selected by this guide.
Every option depends on individual clinical review and availability. Any indicated therapy is an additional patient cost, discussed before you decide.
The Forme approach
The option comes after understanding.
The care relationship matters as much as the question that brought you here. Labs, history, strength, nutrition, and what is workable in real life give a clinician context for any therapy discussion.
Start with your full picture
Goals, history, current medications, symptoms and a comprehensive starting lab panel help frame an assessment.
Discuss options and tradeoffs
Dr. Schaffner reviews evidence, safety, alternatives, legal availability and your preferences. A category or catalog listing never determines eligibility.
Know the separate cost first
If a therapy is appropriate and available, its expected cost is discussed separately before you decide. Membership fees cover the Forme foundation, not medication.
Keep the whole plan connected
Clinical follow-up stays with the clinician. Sami’s coaching supports strength, nourishment and daily habits within the agreed care plan.
A clear boundary
Education is useful.
Prescribing is personal.
Several options here are investigational or lack strong human evidence for these goals. A research catalog entry is not FDA approval, proof of benefit, or a promise that Forme can offer it.
- Tirzepatide requires an individual clinical indication and dose decision; lower-than-labeled approaches need their own discussion.
- MIC+B12 is a nutrient combination, not a peptide or an established fat-loss treatment.
- SS-31/elamipretide has an FDA-approved use for Barth syndrome, not general longevity.
- GLOW is a proposed combination in this guide; its exact ingredients, quality and status need confirmation.
- Research-use products are not patient medications or Forme’s supply pathway.
A little more clarity
Questions worth bringing in.
Is therapy included in Month 1?
No. The $2,198 initial membership fee is paid as $1,200 in Month 1 and $499 in each of Months 2 and 3. No prescription medication or peptide therapy is included in any month. A clinician-recommended therapy would be an additional patient cost discussed before you decide.
Does choosing a path determine what I receive?
No. Weight Loss, Performance and Longevity describe starting goals. Your medical history, assessment, labs, preferences, evidence and applicable rules govern any clinical recommendation. A strength or nutrition plan may be the appropriate focus without medication.
Does “possible” mean Forme offers every example?
No. These are educational examples the founders identified for discussion. Several are investigational, have limited human data or face evolving compounding restrictions. Dr. Schaffner must verify clinical and legal availability; some may never be offered.
What should I ask about a proposed product?
Ask what it is intended to address, what evidence applies to you, whether it is FDA-approved or compounded, expected benefits and risks, alternatives, monitoring, where it comes from, and its full separate cost. Avoid buying “research use only” products for personal use.
Your next question
What makes sense for me?
Bring that question to a Forme conversation. The answer begins with understanding your biology and your life, not choosing an item from a list.